Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Public synthesis

Scope synthesis

Analyst-written narratives for every active scope. Each page has three reading depths: key findings, technical analysis, full appendix — pick your depth when you arrive.

H5N1

H5N1 semen-transmission hypothesis approaches Apr 28 resolution with no confirming data; Cambodia YTD at 4 cases; connector coverage impaired.

Apr 22, 2026

Antimicrobial Resistance

AMR evidence cycle is dry; PubMed stale and multiple connectors at staleness >1.0; two hypotheses approach Apr 27 resolution with no incoming data.

Apr 22, 2026

HIV/AIDS Surveillance

All HIV/AIDS connectors stale from Apr 21 timeouts; zero HIV-specific evidence this cycle; hypotheses unchanged at prior confidence levels.

Apr 22, 2026

Arboviral Expansion

Hong Kong reports first locally acquired dengue case of 2026; Guangzhou chikungunya epidemic-size study confirms massive underreported 2025 burden; multi-regional CHIK escalation signal strengthening.

Apr 22, 2026

Viral Hemorrhagic Fevers

Uganda Sudan Virus Disease outbreak declared over (Final Brief 16); Nigeria Lassa trajectory unchanged; Marburg male reproductive persistence study advances surveillance design.

Apr 22, 2026

Mpox (Clade I and II)

Clade Ib European multi-mode transmission ongoing; new research confirms MPXV replication in vaginal/ectocervical cells, strengthening non-sexual mucosal route concern.

Apr 22, 2026

Novel Coronavirus Surveillance

MERS camel-to-human confirmed in Somalia; BA.3.2 wastewater data absent; no novel sarbecovirus emergence signal.

Apr 22, 2026